Review



anti hmgb1 pe conjugated antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Bioss anti hmgb1 pe conjugated antibody
    Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the <t>HMGB1</t> level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001
    Anti Hmgb1 Pe Conjugated Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hmgb1 pe conjugated antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    anti hmgb1 pe conjugated antibody - by Bioz Stars, 2026-02
    92/100 stars

    Images

    1) Product Images from "Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy"

    Article Title: Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy

    Journal: Journal of Nanobiotechnology

    doi: 10.1186/s12951-022-01736-8

    Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the HMGB1 level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001
    Figure Legend Snippet: Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the HMGB1 level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001

    Techniques Used: Binding Assay, Activity Assay, Enzyme-linked Immunosorbent Assay, Expressing, Flow Cytometry



    Similar Products

    anti hmgb1 pe conjugated antibody  (Bioss)
    92
    Bioss anti hmgb1 pe conjugated antibody
    Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the <t>HMGB1</t> level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001
    Anti Hmgb1 Pe Conjugated Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hmgb1 pe conjugated antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    anti hmgb1 pe conjugated antibody - by Bioz Stars, 2026-02
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the HMGB1 level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Journal of Nanobiotechnology

    Article Title: Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy

    doi: 10.1186/s12951-022-01736-8

    Figure Lengend Snippet: Nanobody binding activity, cellular O 2 production, and ICD induction of Fe-PHCN@DOX nano-nuclear-reactors. A The binding activity of PD-L1 antigen with BSA, anti-PD-L1 nanobody (Nab), and anti-PD-L1 antibody (ab) was measured by ELISA. B O 2 generation in CT26 cells treated with different groups. The scale bar is 100 μm. The ATP content ( C ), the HMGB1 level in nuclei ( D ), and the CRT expression on the surface of CT26 cells ( E , F ) after different group treatment. G , H Quantification of CD80 and CD86 expression on the surface of DC2.4 cells after different treatment by flow cytometry. I ELISA analysis of the levels of cytokines IL-6 secreted by DC2.4 cells in the medium. The scale bar is 25 μm. The p values were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as the mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Anti-HMGB1/PE conjugated antibody was purchased from Bioss.

    Techniques: Binding Assay, Activity Assay, Enzyme-linked Immunosorbent Assay, Expressing, Flow Cytometry